Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 3

Pharmacological Vitreolysis and Pneumatic Vitreolysis

Farmakolojik Vitreolizis ve Pnömatik Vitreolizis

Pages
313–319
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, recent studies evaluating pharmacologic vitreolysis and pneumatic vitreolysis methods were evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Treatment of vitreoretinal interface diseases can be successfully performed with surgical methods, but serious complications could be seen in this method.
📊
Key Findings & Data:In this method, the vitreous structure is chemically altered without any need for surgery, thus vitreous can be effectively and safely separated from the retina.
💡
Conclusion & Impact:In this study, recent studies evaluating pharmacologic vitreolysis and pneumatic vitreolysis methods were evaluated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Treatment of vitreoretinal interface diseases can be successfully performed with surgical methods, but serious complications could be seen in this method. As an alternative to surgery, pharmacologic vitreolysis has been developed. In this method, the vitreous structure is chemically altered without any need for surgery, thus vitreous can be effectively and safely separated from the retina. Ocriplasmin has been detected as most successful agent in the literature. Pneumatic vitreolysis is another treatment method used in the treatment of vitreoretinal interface diseases. Pneumatic vitreolysis is an intravitreal injection of an expansile gas bubble that can be used to massage the vitreomacular interface thereby yielding traction release. In this study, recent studies evaluating pharmacologic vitreolysis and pneumatic vitreolysis methods were evaluated.

Özet

Vitreoretinal ara yüzey hastalıklarının tedavisi cerrahi yöntemle başarılı bir şekilde yapılabilmektedir fakat bu yöntemde ciddi komplikasyonlar görülebilmektedir. Cerrahiye alternatif olarak farmakolojik vitreolizis yöntemi geliştirilmiştir. Bu yöntemde vitreus yapısının cerrahiye gerek kalmaksızın kimyasal olarak değiştirilerek vitreusun etkili ve güvenli bir şekilde retinadan ayrılmasını sağlanmaktadır. Okriplazmin literatürde tespit edilen en başarılı tedavi ajanı olmuştur. Pnömatik vitreolizis vitreoretinal ara yüzey hastalıklarının tedavisinde kullanılan diğer bir tedavi yöntemidir. İntravitreal genleşebilen gazların vitreoretinal ara yüzeye masaj uygulayarak traksiyonları serbestleştirmesini sağlayan yönteme pnömatik vitreolizis adı verilmektedir. Bu çalışmada farmakolojik vitreolizis ve pnömatik vitreolizis yöntemlerini inceleyen son çalışmalar değerlendirilmiştir.

🔖

Cite This Article

ŞAHAN, B., TATLIPINAR, S. (2018). Pharmacological Vitreolysis and Pneumatic Vitreolysis. Güncel Retina Dergisi, Cilt: 2 - Sayı: 3, 313–319. https://ajindex.com/articles/173581

References (11)

  1. Kakehashi A, Takezawa M, Akiba J. Classification of posterior vitreous detachment. Clin Ophthalmol. 2013;8:1-10. Sebag J. Pharmacologic vitreolysis. Retina. 1998;18:1-3. Kaynak S. Vitreomaküler Traksiyon Sendromu ve Epiretinal Membranlarda OCT: Tanı ve Takipteki Önemi. Ret-Vit. 2009;17(1):1-8.
  2. Wang J, McLeod D, Henson DB, Bishop PN. Age-dependent changes in the basal retinovitreous adhesion. Investig Ophthalmol Vis Sci. 2003;44(5):1793- 1800. Sebag J. Ageing of the vitreous. Eye. 1987;1(2):254-262.
  3. Brown DJ, Bishop P, Hamdi H, Kenney MC. Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2. Curr Eye Res. 1996;15(4):439-445. Kadayıfçılar S. Yaşlanan Vitreus. Ret-Vit. 2011;19:221-224.
  4. Ueno N, Sebag J, Hirokawa H, Chakrabarti B. Effects of visible-light irradiation on vitreous structure in the presence of a photosensitizer. Exp Eye Res. 1987;44(6):863-870.
  5. Vaughan-Thomas A, Gilbert SJ, Duance VC. Elevated levels of proteolytic enzymes in the aging human vitreous. Investig Ophthalmol Vis Sci. 2000;41(11):3299-3304.
  6. Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001;119(10):1475-1479. Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc. 2005;103:537-567. Johnson MW. Posterior Vitreous Detachment: Evolution and Complications of Its Early Stages. Am J Ophthalmol. 2010;149(3):371-382.
  7. Duker JS, Kaiser PK, Binder S, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611-2619.
  8. Mojana F, Cheng L, Bartsch DUG, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008;146(2):218-227.
  9. Jackson TL, Nicod E, Angelis A, et al. Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis. Retina. 2013;33(6):1099-1108.
  10. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol. 2005;139(4):638-652.
  11. Robison C, Krebs I, Binder S, et al. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol. 2009;148(1):